IPSC
Century Therapeutics Inc
1.50$
+14.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 15 | Q4 16 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -50.5% | -100.0% | – | – | – | – | – | – | – | – | +31.9% | +59.3% | -76.6% | +230.1% | -94.2% | +49.5% | +81.1% | +219.0% | -9.8% | +2.6% | +427.6% | +2,516.0% | -100.0% | – | – | – | – | – | |
| – | -47.4% | – | – | – | – | – | -1.4% | +11.7% | +80.6% | +1,024.5% | -92.1% | +66.3% | +22.0% | -35.9% | +11.0% | +846.0% | -2.2% | -85.5% | +7.3% | -4.8% | +0.6% | – | – | -16.1% | -84.2% | -15.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +31.9% | +59.3% | -228.7% | – | – | -22,968.7% | – | – | -9.8% | +2.6% | +427.6% | +2,516.0% | -124.6% | – | – | – | – | – | |
| – | -20.5% | -12.6% | +6.8% | +27.4% | +15.1% | +23.6% | +23.1% | +3.2% | +11.5% | -2.8% | +15.6% | +5.7% | -1.2% | -2.7% | -8.7% | +17.9% | -13.0% | +0.5% | +16.2% | +0.0% | +7.9% | -9.5% | +1.0% | -16.1% | -12.6% | -28.4% | +39.0% | – | |
| – | -25.2% | -97.5% | +12.7% | +0.4% | +21.4% | -4.5% | +52.1% | +53.7% | -1.7% | +18.1% | +13.1% | -2.3% | +2.2% | +8.0% | -7.6% | +9.2% | -4.4% | +1.8% | -5.0% | +0.6% | -7.1% | +8.4% | -7.2% | -12.4% | -86.0% | +588.2% | -12.0% | – | |
| – | – | – | +5.2% | +24.9% | +16.2% | +12.2% | +29.1% | +12.2% | +5.3% | +47.6% | -14.9% | +3.7% | -10.4% | +3.9% | +11.2% | -63.1% | +67.4% | +48.0% | +10.5% | +0.2% | +16.5% | -15.6% | -77.7% | +74.2% | +51.9% | +8.9% | +62.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -146.7% | – | – | – | – | – | |
| – | +23.5% | -98.9% | -32.8% | -72.6% | +362.7% | +15.0% | +1.3% | +1.3% | -88.2% | +726.3% | +5.1% | +13.0% | +10.7% | -2.2% | -66.3% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -142.5% | – | – | – | – | – | |
| – | – | – | – | – | +881.1% | -67.1% | -102.9% | – | -31.7% | -62.8% | +12.5% | +38.9% | +28.0% | +3,675.0% | -21.4% | -37.7% | -246.8% | – | +2,100.0% | -136.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -142.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -136.8% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.